Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Ownership Summary
Mirum Pharmaceuticals is owned by 77.50% institutional investors, 1.71% insiders, and 20.79% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 13.66% of MIRM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.87% of its assets in Mirum Pharmaceuticals shares.
MIRM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mirum Pharmaceuticals | 77.50% | 1.71% | 20.79% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 6.80M | 13.66% | $498.15M |
| Janus henderson group | 4.58M | 9.59% | $189.48M |
| Blackrock | 3.24M | 6.90% | $110.71M |
| Blackrock funding, inc. /de | 3.65M | 6.27% | $287.94M |
| Eventide asset management | 2.52M | 5.07% | $184.92M |
| Vanguard group | 2.60M | 4.47% | $205.07M |
| Bvf inc/il | 1.50M | 3.01% | $109.62M |
| State street | 1.35M | 2.71% | $98.74M |
| Price t rowe associates inc /md/ | 1.28M | 2.58% | $94.08M |
| Novo | 1.26M | 2.54% | $92.67M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Frazier life sciences management | 6.80M | 14.93% | $498.15M |
| Boone capital management | 535.73K | 12.88% | $39.27M |
| First turn management | 570.57K | 6.28% | $41.83M |
| Novo | 1.26M | 5.97% | $92.67M |
| Patient square capital lp | 298.68K | 5.05% | $23.59M |
| Bvf inc/il | 1.50M | 4.44% | $109.62M |
| Tang capital management | 1.24M | 3.49% | $90.61M |
| Highlander partners | 122.98K | 3.49% | $9.71M |
| Rock springs capital management lp | 761.13K | 3.26% | $55.80M |
| Eventide asset management | 2.52M | 3.04% | $184.92M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.24M | 0.00% | 785.78K |
| Wellington management group llp | 790.69K | 0.01% | 672.12K |
| Fmr | 640.22K | 0.00% | 580.78K |
| Arrowstreet capital, limited partnership | 612.32K | 0.03% | 536.67K |
| Point72 asset management | 790.67K | 0.10% | 531.81K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | 1.50M | 4.44% | -1.27M |
| Bioimpact capital | - | - | -589.58K |
| Cadian capital management, lp | - | - | -475.71K |
| Macquarie group | - | - | -393.21K |
| Checkpoint capital | - | - | -362.19K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 263.18K | 0.00% | 263.18K | $20.79M |
| Axa investment managers | 255.69K | 0.05% | 255.69K | $18.74M |
| Handelsbanken fonder ab | 213.50K | 0.05% | 213.50K | $16.86M |
| D. e. shaw | 157.35K | 0.00% | 157.35K | $6.51M |
| Voleon capital management lp | 86.53K | 0.15% | 86.53K | $6.34M |
Sold Out
| Holder | Change |
|---|---|
| Coldstream capital management | -1.00 |
| Tortoise investment management | -2.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Northwestern mutual wealth management | -9.00 |
| Stephens consulting | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 219 | -21.22% | 45,026,857 | -21.48% | 77 | 0.80% | 124 | -24.39% | 63 | -18.18% |
| Sep 30, 2025 | 99 | -54.59% | 7,010,413 | -87.34% | 14 | 0.11% | 58 | -48.21% | 28 | -64.10% |
| Jun 30, 2025 | 216 | 0.47% | 55,383,162 | 4.20% | 111 | 0.94% | 110 | -9.84% | 78 | 23.81% |
| Mar 31, 2025 | 215 | 4.37% | 54,155,788 | 2.17% | 110 | 0.90% | 121 | 5.22% | 65 | 6.56% |
| Dec 31, 2024 | 194 | 5.43% | 43,660,980 | -17.71% | 91 | 0.74% | 109 | -3.54% | 56 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.41M | 2.87% | 1.77K |
| Eventide Gilead N | 1.43M | 2.37% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.35M | 2.24% | 3.87K |
| State Street® SPDR® S&P® Biotech ETF | 1.26M | 2.08% | -6.73K |
| Eventide Healthcare & Life Sciences I | 1.08M | 1.79% | -114.73K |
| iShares Russell 2000 ETF | 984.07K | 1.63% | 640.83K |
| MEDICAL BioHealth EUR Acc | 756.50K | 1.59% | - |
| Janus Henderson US SMID Cap Growth MA | 679.10K | 1.37% | 679.10K |
| Janus Henderson Triton D | 798.07K | 1.32% | -6.01K |
| Janus Henderson US SMID Cap Growth | 798.07K | 1.32% | -35.31K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 13, 2026 | Ramasastry Saira | - | Sell | $204.18K |
| Feb 02, 2026 | Radovich Peter | PRESIDENT AND COO | Sell | $271.79K |
| Feb 02, 2026 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | $940.89K |
| Feb 02, 2026 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $100.00K |
| Jan 26, 2026 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | $101.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 1 | 14 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 10 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | 10 | 21 |
MIRM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools